drugset / Trial / NCT05147415
Study of Tesomet With Open-label Extension in Subjects With Hypothalamic Obesity (HO)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will evaluate the safety and efficacy of Tesomet (tesofensine + metoprolol) in subjects 18 years of age or older, with HO
Timeline
- Start
- 2021-11-11
- Primary completion
- 2022-12-09
- Completion
- 2022-12-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metoprolol | Other / unclassified | — | Oral |
| Subject | Tesofensine | Small molecule | — | Oral |